Cytosorbents Corp — Director's Dealing 2013

Jul 17, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2013-04-04

Reporting Person: Rubin Joseph (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-04-04	Stock Option	$0.115	A	150000	Acquired	2023-04-04	Common Stock (150000)	Direct

Footnotes

F1: The options will become exercisable based on the achievement of certain milestones connected to the Company's operations, subject to approval by the Board of Directors.

F2: As compensation for services rendered, on April 4, 2013, Mr. Joseph Rubin was issued an option to purchase 150,000 shares of common stock at an exercise price of $0.115 per share which will expire on April 4, 2023.